Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults

Author:

Diener Hans-Christoph1,Tassorelli Cristina23ORCID,Dodick David W4,Silberstein Stephan D5ORCID,Lipton Richard B6,Ashina Messoud7,Becker Werner J89,Ferrari Michel D10,Goadsby Peter J11ORCID,Pozo-Rosich Patricia12,Wang Shuu-Jiun1314ORCID,Houle Timothy T15,Hoek Thomas C van den16,Martinelli Daniele23ORCID,Terwindt Gisela M10,

Affiliation:

1. Institute for Medical Informatics, Biometry and Epidemiology, University Duisburg-Essen, Essen, Germany

2. Headache Science Center, C. Mondino Foundation (IRCCS), Pavia, Italy

3. Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy

4. Department of Neurology, Mayo Clinic, Phoenix, AZ, USA

5. Jefferson Headache Center, Thomas Jefferson University, Philadelphia, PA, USA

6. Montefiore Headache Center, Department of Neurology and Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA

7. Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark

8. Dept of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada

9. Hotchkiss Brain Institute, Calgary, Canada

10. Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands

11. National Institute for Health Research-Wellcome Trust King’s Clinical Research Facility, King’s College London, UK

12. Headache Unit, Neurology Department, Vall d’Hebron University Hospital & Headache Research Group, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain

13. Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan

14. Brain Research Center and School of Medicine, National Yang-Ming University, Taipei, Taiwan

15. Harvard Medical School, Boston, MA, USA

16. Leiden University Medical Center, Leiden, the Netherlands

Abstract

Clinical trials are a key component of the evidence base for the treatment of headache disorders. In 1991, the International Headache Society Clinical Trials Standing Committee developed and published the first edition of the Guidelines for Controlled Trials of Drugs in Migraine. Advances in drugs, devices, and biologicals, as well as novel trial designs, have prompted several updates over the nearly 30 years since, including most recently the Guidelines for controlled trials of preventive treatment of chronic migraine (2018), the Guidelines for controlled trials of acute treatment of migraine attacks in adults (2019), and Guidelines for controlled trials of preventive treatment of migraine in children and adolescents (2019). The present update incorporates findings from new research and is intended to optimize the design of controlled trials of preventive pharmacological treatment of episodic migraine in adults. A guideline for clinical trials with devices will be published separately.

Publisher

SAGE Publications

Subject

Neurology (clinical),General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3